18 rams (2-3 years old, bodyweight: 30-50 kg) and 50 ewes (44 donors and 6 for rams training, 2-3 years old, bodyweight: 30-40 kg) of the Shaanbei Cashmere goat breed were used for this study.
plasmid into competent cells (DH5α). Cells were cultured for eight hours for rapid amplification.
Finally, we extracted the U6-sgRNA and Cas9 plasmid using the Endo-free Plasmid Purification Kit (TaKaRa, Dalian, China) .
Optimization of the CRISPR system in goat fetal fibroblasts
We established a fibroblast cell line from 45-day-old goat fetus trunk tissue and collected cells at the fourth generation for transfection. Cell-culture medium A consists of 10% FBS (ThermoFisher, Gibco, Australia), 100 μg/mL penicillin, 100 μg/mL streptomycin, and DMEM medium (ThermoFisher, Gibco, USA). 10 sgRNA plasmids and Cas9 plasmid were transfected into a 12-well plate to verify the efficiency in goat fetal fibroblasts. The transfection procedure was conducted using Lipofectamine 3000 Reagent (ThermoFisher, Gibco, USA) according to the manufacturer's instructions.
After transfection, we used 1.2 μg/mL purinomycin and 28 μg/mL blasticidin to screen the cells for 2 days, followed by culture in cell-culture medium (DMEM-F12; Gibco, Rockville, MD). Next, cells were changed to cell-culture medium A for 24 h until they covered the entire culture dish. Genomic DNA was extracted via the Universal Genomic DNA Kit (CWBIO, China).
T7E1 cleavage and sequencing
To quantitatively measure the quality of the obtained genomic DNA, we used high-fidelity Taq polymerase (TOYOBO, Japan) to amplify the target gene fragment and for the subsequent Sanger sequencing (Table S6) . Furthermore, the products were purified with a PCR Cleanup Kit (Omega, USA Norcross, GA), then immediately digested via T7E1 assay (NEB, Beijing, China) for 30 min at 37°C after denaturation and re-annealing with NEBuffer 2. The digestive results were separated via 2.5% agarose gel electrophoresis. We defined the grey value of unedited bands as label a, and labeled the edited bands as b and c, the formula to calculate the targeting efficiency of each sgRNA is as follows:
Off-target assay
To determine off-target effects of each sgRNA, we determined the specificity of sgRNAs, using sgRNAcas9 (Xie et al. 2014 ) to predict possible off-target loci and sequences. Next, we designed specific primers for each off-target site (Table S6) , using PCR analysis and T7E1 enzyme digestion to detect the knock-out in off-target sites, according to our previous study (Wang et al. 2015) .
Preparation of the zygote injection mixture
We used DNA oligo sg8 to anneal the double-strand and sub-cloned it into the pUC57kan-T7-sgRNA (T7-sg8) vector. Next, a fragment containing T7 promoter and sg8 sequence was obtained via amplification with PrimerSTAR HS DNA polymerase (Takara, Beijing, China). Then, sgRNA was produced via the MEGA shortscript kit (Life Technologies, Ambion, USA) and was purified via the MEGA clear kit (Life Technologies, Ambion, USA). The pST1374-Cas9-ZFNLS (Cas9) plasmid was the in vitro transcription template and we linearized the Cas9 plasmid by Age Ι endonuclease (NEB, Beijing China), then transcript it in vitro via the mMESSAGE mMACHINE T7 Ultra Kit (Life Technologies, Ambion, USA) and used the RNeasy Mini Kit (Qiagen, Germany) to purified the Cas9 mRNA. The sgRNA and Cas9 mRNA were mixed at varied ratios according Table S5 , and were stored at -80°C for further study.
Microinjection of Cas9/sgRNA system in goat zygotes
Healthy ewes (2 -3-year-old) with regular estrus were selected as donors for zygote collection. These donors were treated with the CIDR Sheep and Goat Device (Eazi-Breed™, Pfizer, NY, USA) via insertion into the vagina for 14 to 16 days. The superovulation was performed with intramuscular injection of exogenous FSH (Folltropin-V, Bioniche Animal Health, Canada) 60 h before removing the CIDR. This treatment was administered via intramuscular injection with FSH for seven times (75, 50, 50, 37.5, 37.5, 25 , and 25 mg each). Treatment with 1 mL prostaglandin was conducted at the time of CIDR removal. The estrous status of the donor was monitored 12 h after CIDR withdrawal for mating.
Zygotes were collected from oviduct via surgery 14 h after the last fertilization, and were transferred into TCM199 medium (ThermoFisher, Gibco, NY, USA). The Cas9 mRNA and sgRNA mixture with varied concentrations were injected into the cytoplasm of zygotes via the FemtoJet system (Eppendorf, Hamburg, Germany). Microinjection was conducted in the manipulation medium TCM199 on a heated platform with the Olympus micromanipulation system ON3. The conditions of injection pressure, injection time, and compensatory pressure were conducted according to (Wang et al. 2016) . After injection, the zygotes were transferred to Quinn's Advantage Blastocyst Medium (Sage Biopharma, NJ, USA) at 38.5°C, 5% concentration of CO2, and saturated humidity conditions. Coordinates of sgRNA target sites are based on the goat genome assembly CHR2.0. 
Target efficacy detection in zygotes

